Products for Research Use Only
RegisterLogin

Veledimex

CAT: 0804-HY-16785-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-16785-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Veledimex (INXN-1001), a synthetic analog of the insect molting hormone ecdysone, is an orally active activator ligand for a proprietary gene therapy promoter system. Veledimex can be used to activate certain genes using the ecdysone receptor (EcR) -based inducible gene regulation system, the RheoSwitch Therapeutic System (RTS) . Veledimex can cross blood-brain barrier (BBB) in both orthotopic GL-261 mice and cynomolgus monkeys[1][2].
CAS Number
1093130-72-3
Product Name Alternative
INXN-1001; RG-115932
UNSPSC
12352005
Target
Interleukin Related
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Veledimex.html
Purity
98.77
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NN(C(C1=CC(C)=CC(C)=C1)=O)[C@@H](C(C)(C)C)CCC)C2=CC=CC(OC)=C2CC
Molecular Formula
C27H38N2O3
Molecular Weight
438.60
References & Citations
[1]Barrett JA, et al. Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma. Cancer Gene Ther. 2018;25 (5-6) :106-116.|[2]Chiocca EA, et al. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial. Sci Transl Med. 2019;11 (505) :eaaw5680.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
IL-1; IL-12

Alternative Products

CatalogName
TTB13072-01Veledimex
A21011-50Veledimex 50mg
MBS5767833Veledimex racemate
A21011-10Veledimex 10mg
A21011-5Veledimex 5mg
A21011-1Veledimex 1mg
GTR19205301-01Veledimex (S enantiomer)

Popular Products